SP Intravenous Chemotherapy Versus SP by HIPEC in Stage Ⅲ Patients After D2 Gastrectomy
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to assess the safety and efficacy of S-1 plus cisplatin hyperthermic
intraperitoneal chemotherapy in stage Ⅲ patients after D2 gastrectomy